Skip to main content
Fig. 6 | Diabetology & Metabolic Syndrome

Fig. 6

From: Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis

Fig. 6

Serum 1,5-AG and AF-AGE levels in diabetic and non-diabetic HD patients. A The mean serum level of 1,5-AG was 2.01 ± 0.778 μg/mL in the non-diabetic group (N = 44) and 2.15 ± 0.898 μg/mL in the diabetic group (N = 32). B The mean serum level of AF-AGEs was 18.5 ± 7.77 U/mL in the non-diabetic group and 18.4 ± 8.89 U/mL in the diabetic group. There was no significant difference between the two groups. 1,5-AG, 1,5-anhydroglucitol; AF-AGEs; 1,5-AF-derived advanced glycation end products; HD, hemodialysis

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us